MOESM2 of Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases

Additional file 2. This file includes all the references screened in the systematic review and the reason for exclusion.

附加文件2。本文件包含系统综述（systematic review）中经过筛选的全部参考文献及其排除理由。